BCWM
RVMD icon

Bartlett & Co Wealth Management’s Revolution Medicines RVMD Stock Holding History

Bartlett & Co Wealth Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$187 Hold
1
– – ﹤0.01% 1269
2026
Q1 		$148 Buy
+1
New +$101 ﹤0.01% 1235
2025
Q1 		– Sell
-1,000
Closed -$43.7K – 1262
2024
Q4 		$43.7K Hold
1,000
– – ﹤0.01% 679
2024
Q3 		$45.4K Hold
1,000
– – ﹤0.01% 671
2024
Q2 		$38.8K Hold
1,000
– – ﹤0.01% 703
2024
Q1 		$32.2K Buy
+1,000
New +$29.6K ﹤0.01% 730

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Bartlett & Co Wealth Management's RVMD Position: Q2 2026 in Review

Bartlett & Co Wealth Management held its Revolution Medicines (RVMD) position steady in Q2 2026 at 1 share worth $187. The position accounts for ﹤0.01% of the portfolio, ranked #1269.

Bartlett & Co Wealth Management first reported a position in RVMD in Q1 2024 and has held it in 6 quarters since. The position peaked at $45.4K in Q3 2024. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Bartlett & Co Wealth Management held 1 share of Revolution Medicines worth $187 as of Q2 2026.
  • Bartlett & Co Wealth Management left its Revolution Medicines share count unchanged in Q2 2026.
  • Revolution Medicines made up ﹤0.01% of Bartlett & Co Wealth Management's portfolio in Q2 2026, its #1269 holding.
  • Bartlett & Co Wealth Management first reported a position in Revolution Medicines in Q1 2024 and has held it in 6 quarters since.
  • Bartlett & Co Wealth Management's Revolution Medicines position peaked at $45.4K in Q3 2024.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Bartlett & Co Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.